LoginRegister

    Lupin gets USFDA nod for generic version of Clobex lotion

    Written by Ruby Khatun Khatun   |  

    New Delhi: Drug maker Lupin said it has received approval from the US health regulator to market anti-inflammatory Clobetasol Propionate lotion in the American market.


    The Mumbai-based firm said in a statement that it has received final approval for its product from the US Food and Drug Administration (USFDA).
    The company's product is a generic version of Galderma Laboratories' Clobex Lotion, which is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.


    As per IMS MAT June data, Clobex had sales of USD 14.3 million in the US market.
    American marketAnti InflammatoryaprrovalClobetasol Propionate lotionClobex lotioncorticosteroid-responsive dermatosesGalderma Laboratoriesgeneric versioninflammatoryLupinmarketpruritic manifestationsUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X